Advertisement
Advertisement

AVTX

AVTX logo

Avalo Therapeutics, Inc. Common Stock

21.57
USD
Sponsored
-1.30
-5.68%
May 08, 16:00 UTC -4
Closed
exchange

Pre-Market

20.91

-0.66
-3.06%

Avalo Therapeutics, Inc. Common Stock Profile

About

Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa.

Info & Links

CEO

Garry Neil

Headquarters

1500 Liberty Ridge Drive, Suite 321
Wayne, PA 19087, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.avalotx.com

Auditor

Ernst & Young LLP

Share holders

145

Employees

33

Avalo Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.09B

Enterprise Value

1.08B

Enterprise Value/EBITDA(ttm)

-14.82

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.17

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-77.91%

Return on Invested Capital(ttm)

-80.55%

Return on Assets(ttm)

-61.78%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-72.64M

Net Income Available to Common(ttm)

-78.26M

Diluted EPS(ttm)

-5.73

Share Statistics

Beta (5Y Monthly)

0.93

52-Week Change

431.28%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

22.79M

Dividend Yield

0.00%

Float4

22.10M

% Held by Insiders

3.03%

% Held by Institutions

87.06%

Balance Sheet

Total Cash(mrq)

98.37M

Total Cash Per Share(mrq)

4.32

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.14%

Quick Ratio(mrq)

8.14%

Book Value Per Share(mrq)

4.49

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.84

Free Cash Flow(ytd)

-51.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement